British American Tobacco PLC (BTI)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 99,275.00 |
|---|---|
| 52-week range | 86,888.00 – 111,112.00 |
| Return, 1 month / 3 months | +9.7% / −2.1% |
| Return, 1 year / 3 years | +11.3% / +117.0% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -20.7% |
| Average daily value traded | 54,580.99M ZAC |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
British American Tobacco is a tobacco company based in London that makes and sells cigarettes and other nicotine products. Its cigarette brands include Dunhill, Kent, Lucky Strike and Pall Mall, and it also offers vaping devices and oral nicotine products. The company sells to adult consumers in many countries through distributors, retailers and its own commercial operations, and it runs research into reduced-risk alternatives to smoking.
The shares are listed on the Johannesburg Stock Exchange in South Africa under the code BTI, and the price on this page is in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
British American Tobacco PLC (BTI) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 99,275.00 on 27 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 82 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.3% and over the last three months it fell 2.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.8% | ||
| From 52-week high | -9.6% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.1% | ||
| 6-month return | 2.7% | ||
| 12-month return, skipping the last month | 1.4% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.7% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 54,580.99M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.8% |
|---|---|
| 1 month | +9.7% |
| 3 months | −2.1% |
| 6 months | +2.7% |
| 1 year | +11.3% |
| 3 years | +117.0% |
| 5 years | +157.5% |
Signals
| 50-day / 200-day average | 91,641.17 / 96,555.24 |
|---|---|
| Golden / death cross (60 days) | Death, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,161.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Dec 2025 | ZAC 1,351.8141 |
| 1 Oct 2025 | ZAC 1,393.2350 |
| 25 Jun 2025 | ZAC 1,460.3408 |
| 26 Mar 2025 | ZAC 1,423.9084 |
| 18 Dec 2024 | ZAC 1,354.7934 |
| 25 Sep 2024 | ZAC 1,373.4467 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.